Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-09-12
2006-09-12
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S495000
Reexamination Certificate
active
07105510
ABSTRACT:
Compounds represented by formula I:wherein R1is H, halogen, (C1-4)alkyl, O(C1-4)alkyl, and haloalkyl; R2is H or (C1-4)alkyl; R3is H or (C1-4)alkyl; R4is (C1-4)alkyl, (C1-4)alkyl(C3-7)cycloalkyl, or (C3-7)cycloalkyl; and Q is a fused phenyl-5 or 6-membered saturated heterocycle having one to two heteroatoms selected from O and N, said Q being optionally substituted with hydroxy, or (C1-4)alkyl which in turn maybe optionally substituted with pyridinyl-N-oxide or C(O)OR wherein R is H or (C1-4)alkyl; or a salt thereof. The compounds have inhibitory activity against Wild Type, and single and double mutants strains, of HIV.
REFERENCES:
patent: 5705499 (1998-01-01), Cywin et al.
patent: 2003/0069226 (2003-04-01), Ogilvie et al.
patent: 2003/0171363 (2003-09-01), Ogilvie et al.
Janice M. Klunder et al; Novel Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase. 7. 8-Arylethyldipyridodiazepinones as Potent Broad-Spectrum Inhibitors of Wild-Type and Mutant Enzymes; J. Med. Chem 1998 vol. 41 pp. 2960-2971; American Chemical Society.
Charles L. Cywin et al; Novel Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase. 8. 8-Aryloxymethyl- and 8-Arylthiomethyldipyridodiazepinones; J. Med. Chem 1998 vol. 41 pp. 2972-2984; American Chemical Society.
Deziel Robert
Malenfant Eric
Ogilvie William
Thavonekham Bounkham
Yoakim Christiane
Boehringer Ingelheim (Canada) Ltd.
Devlin Mary-Ellen M.
Kifle Bruck
Morris Michael P.
Stempel Alan R.
LandOfFree
Non-nucleoside reverse transcriptase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-nucleoside reverse transcriptase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-nucleoside reverse transcriptase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3583986